Medindia

X

Simple Stroke Prevention is Best

by Medindia Content Team on  June 11, 2003 at 4:12 PM General Health News   - G J E 4
Simple Stroke Prevention is Best
Aspirin appears to be a better treatment than the antiplatelet drug ticlopidine for preventing recurrent strokes in black patients, according to new research in this week's issue of the Journal of the American Medical Association. The study included 1,809 black men and women who recently had strokes that were not due to bleeding in the brain or to blockage of a blood vessel in the brain. Participants received either a daily 500-milligram dose of ticlopidine or a daily 650-milligram dose of aspirin.
Researchers hypothesized ticlopidine would be more effective in black ischemic stroke patients than aspirin. The study was halted after 6.5 years when researchers found the exact opposite. In fact, study results suggest a 40-percent to 50-percent likelihood of aspirin being significantly better in reducing stroke risk if the study were to continue to completion. Investigators conclude, "Aspirin is much less expensive than other major antiplatelet agents, is readily available, easy to use, and relatively safe."

Advertisement
Blacks are about twice as likely as most other individuals in the United States to die from or experience stroke. In an accompanying editorial, Ralph Sacco, M.S., M.D., from New York Presbyterian Hospital, says, "The study provides new data on an alternate antiplatelet agent (ticlopidine) that should no longer be recommended for prevention of recurrent stroke -- certainly not in black patients."
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All